Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 7,662,926

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,662,926
Title:Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
Abstract: The present application describes antibodies that selectively bind human Fc.gamma.RIIB, with little or no binding to other human Fc.gamma.Rs, e.g., human Fc.gamma.RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc.gamma.RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
Inventor(s): Chan; Andrew C. (Menlo Park, CA), Shields; Robert L. (San Mateo, CA), Wu; Lawren (Foster City, CA)
Assignee: Genentech, Inc. (South San Francisco, unknown)
Application Number:11/624,523
Patent Claims:see list of patent claims

Details for Patent 7,662,926

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20 ➤ Sign Up Genentech, Inc. (South San Francisco, unknown) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.